Ruxolitinib/nilotinib cotreatment inhibits leukemia-propagating cells in Philadelphia chromosome-positive ALL-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ruxolitinib/nilotinib cotreatment inhibits leukemia-propagating cells in Philadelphia chromosome-positive ALL

Published:2017-08-30 Issue:1 Volume:15 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Kong Yuan,Wu Yi-Lin,Song Yang,Shi Min-Min,Cao Xie-Na,Zhao Hong-Yan,Qin Ya-Zhen,Lai Yue-Yun,Jiang Hao,Jiang Qian,Huang Xiao-Jun

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-017-1286-5.pdf

Reference52 articles.

1. Cilloni D, Saglio G. Molecular pathways: BCR–ABL. Clin Cancer Res. 2012;4:930–7.

2. Fielding AK. How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. 2010;18:3409–17.

3. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008;9617:1030–43.

4. Fielding AK, Rowe JM, Buck G, Foroni L, Gerrard G, Litzow MR, et al. UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia. Blood. 2014;6:843–50.

5. Mizuta S, Matsuo K, Nishiwaki S, Imai K, Kanamori H, Ohashi K, et al. Pretransplant administration of imatinib for allo-HSCT in patients with BCR–ABL-positive acute lymphoblastic leukemia. Blood. 2014;15:2325–32.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Therapy and Personalized Medicine;Therapeutic Approaches in Cancer Treatment;2023

2. Novel Treatments for Pediatric Relapsed or Refractory Acute B-Cell Lineage Lymphoblastic Leukemia: Precision Medicine Era;Frontiers in Pediatrics;2022-06-23

3. Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib;Scientific Reports;2022-05-19

4. Improved function and balance in T cell modulation by endothelial cells in young people;Clinical and Experimental Immunology;2021-08-22

5. Autophagy in endothelial cells regulates their haematopoiesis-supporting ability;EBioMedicine;2020-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3